Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (151-160 of 343) with videos related to

Pageof 35
Sort By:
Oncology|May 15, 2008
Epidermal growth factor receptor-directed therapy in esophageal cancerA U Pande, R V Iyer, A Rani, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Oncology|April 15, 2010
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomasShelly S Lo, Alok A Khorana, Milind Javle, et al.
JCO Precision Oncology|June 3, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into ResponseSupriya Peshin, Fen Saj, Pashtoon M Kasi, et al.
Surgical Oncology|January 7, 2022
Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinomaElena Panettieri, Harufumi Maki, Bradford J Kim, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
Annals of Surgical Oncology|February 15, 2021
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant ExperienceMeredith C Mason, Nader N Massarweh, Ching-Wei D Tzeng, et al.
Oncogene|August 29, 2012
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinomaN Kunkeaw, S H Jeon, K Lee, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2011
Radiation treatment outcomes for unresectable hepatocellular carcinomaHeath D Skinner, Hadley J Sharp, Ahmed O Kaseb, et al.
Cancer|February 19, 2010
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinomaManal M Hassan, Steven A Curley, Donghui Li, et al.
Pageof 35

Showing results (151-160 of 343) with videos related to

Sort By:
Pageof 35
Oncology|May 15, 2008
Epidermal growth factor receptor-directed therapy in esophageal cancerA U Pande, R V Iyer, A Rani, et al.
Cancer|November 19, 2016
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 studyPat Gulhati, Kanwal Raghav, Rachna T Shroff, et al.
Oncology|April 15, 2010
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomasShelly S Lo, Alok A Khorana, Milind Javle, et al.
JCO Precision Oncology|June 3, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into ResponseSupriya Peshin, Fen Saj, Pashtoon M Kasi, et al.
Surgical Oncology|January 7, 2022
Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinomaElena Panettieri, Harufumi Maki, Bradford J Kim, et al.
The Oncologist|August 16, 2022
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017Milind Javle, Sunyoung Lee, Nilofer S Azad, et al.
Annals of Surgical Oncology|February 15, 2021
Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant ExperienceMeredith C Mason, Nader N Massarweh, Ching-Wei D Tzeng, et al.
Oncogene|August 29, 2012
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinomaN Kunkeaw, S H Jeon, K Lee, et al.
Acta Oncologica (Stockholm, Sweden)|July 29, 2011
Radiation treatment outcomes for unresectable hepatocellular carcinomaHeath D Skinner, Hadley J Sharp, Ahmed O Kaseb, et al.
Cancer|February 19, 2010
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinomaManal M Hassan, Steven A Curley, Donghui Li, et al.
Pageof 35